Form 4: TransMedics Group Director James R. Tobin Sells Shares
SEC Form 4
James R. Tobin, a director at TransMedics Group, Inc., sold shares of common stock on August 8, 2024.
Summary
- On August 8, 2024, James R. Tobin, a director of TransMedics Group, Inc., sold 12,664 shares of common stock at a weighted average price of $158.96.
- He also sold 7,336 shares of common stock at a weighted average price of $159.96.
- Following these transactions, Tobin directly owns 1,925 shares and indirectly owns 173,146 shares through the James R. Tobin 2012 Trust.
- The sales were executed at varying prices within the ranges of $158.75 to $159.74 and $159.77 to $160.31.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock sales. The sentiment is neither positive nor negative as it simply reports transactions.
Industry Context
This is a routine disclosure of stock sales by a company insider, which is common for publicly traded companies. It provides transparency into the trading activities of individuals with significant knowledge of the company.
Stakeholder Impact
- The sale of shares by a director could potentially create short-term uncertainty among shareholders.
Key Dates
| Date | Description |
|---|---|
| 08/08/2024 | Date of the stock sale transactions |
| 08/09/2024 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.